Brian Weinstein
Stock Analyst at William Blair
(0.26)
# 3,632
Out of 4,667 analysts
10
Total ratings
28.57%
Success rate
-17.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brian Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Downgrades: Market Perform | n/a | $13.32 | - | 2 | Jul 15, 2022 | |
| GKOS Glaukos | Upgrades: Outperform | n/a | $141.44 | - | 3 | Feb 3, 2022 | |
| SERA Sera Prognostics | Initiates: Outperform | n/a | $6.03 | - | 1 | Aug 9, 2021 | |
| BDSX Biodesix | Initiates: Outperform | n/a | $1.19 | - | 1 | Nov 23, 2020 | |
| AWH Aspira Women's Health | Initiates: Outperform | n/a | $0.73 | - | 1 | Oct 30, 2020 | |
| QDEL QuidelOrtho | Upgrades: Outperform | n/a | $37.48 | - | 2 | Jul 18, 2017 |
10x Genomics
Jul 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $13.32
Upside: -
Glaukos
Feb 3, 2022
Upgrades: Outperform
Price Target: n/a
Current: $141.44
Upside: -
Sera Prognostics
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.03
Upside: -
Biodesix
Nov 23, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.19
Upside: -
Aspira Women's Health
Oct 30, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.73
Upside: -
QuidelOrtho
Jul 18, 2017
Upgrades: Outperform
Price Target: n/a
Current: $37.48
Upside: -